Nathalie Riebel, MBA

Clinical Advisor

Nathalie brings more than 30 years of experience in clinical operations, drug development, and oncology research. She has served in senior leadership roles at major biotech and pharmaceutical companies; including responsibilities at PDS Biotechnology Corporation, Delcath Systems, Eli Lilly and Company/ ImClone Systems and several CROs, driving first-in-human (FIH) to phase 3 programs and cross-functional global teams.

As Clinical Advisor to Lumigen, Nathalie guides the design and execution of clinical development strategies for our targeted oncology programs. She is recognized for streamlining operations, ensuring inspection readiness and accelerating pathways to the clinic.

Nathalie holds an MBA from Walden University and a Bachelor of Science from McGill University.